Next Article in Journal / Special Issue
In Vivo Efficacy and Toxicity Studies of a Novel Antibacterial Agent: 14-O-[(2-Amino-1,3,4-thiadiazol-5-yl)Thioacetyl] Mutilin
Previous Article in Journal
Optimization of Solid-Supported Glaser-Hay Reactions in the Microwave
Previous Article in Special Issue
Inhibitory Effect of Duabanga grandiflora on MRSA Biofilm Formation via Prevention of Cell-Surface Attachment and PBP2a Production
Review

Antibiotic Discovery: Combatting Bacterial Resistance in Cells and in Biofilm Communities

1
Department of Chemistry and Biomolecular Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW 2109, Australia
2
Department of Biological Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW 2109, Australia
*
Author to whom correspondence should be addressed.
Academic Editor: Peter J. Rutledge
Molecules 2015, 20(4), 5286-5298; https://doi.org/10.3390/molecules20045286
Received: 12 February 2015 / Revised: 11 March 2015 / Accepted: 18 March 2015 / Published: 24 March 2015
Bacterial resistance is a rapidly escalating threat to public health as our arsenal of effective antibiotics dwindles. Therefore, there is an urgent need for new antibiotics. Drug discovery has historically focused on bacteria growing in planktonic cultures. Many antibiotics were originally developed to target individual bacterial cells, being assessed in vitro against microorganisms in a planktonic mode of life. However, towards the end of the 20th century it became clear that many bacteria live as complex communities called biofilms in their natural habitat, and this includes habitats within a human host. The biofilm mode of life provides advantages to microorganisms, such as enhanced resistance towards environmental stresses, including antibiotic challenge. The community level resistance provided by biofilms is distinct from resistance mechanisms that operate at a cellular level, and cannot be overlooked in the development of novel strategies to combat infectious diseases. The review compares mechanisms of antibiotic resistance at cellular and community levels in the light of past and present antibiotic discovery efforts. Future perspectives on novel strategies for treatment of biofilm-related infectious diseases are explored. View Full-Text
Keywords: infection control; opportunistic pathogens; bacterial evolution; eDNA; quorum sensing; biofilm matrix; unculturable microorganisms; drug discovery; natural products infection control; opportunistic pathogens; bacterial evolution; eDNA; quorum sensing; biofilm matrix; unculturable microorganisms; drug discovery; natural products
Show Figures

Figure 1

MDPI and ACS Style

Penesyan, A.; Gillings, M.; Paulsen, I.T. Antibiotic Discovery: Combatting Bacterial Resistance in Cells and in Biofilm Communities. Molecules 2015, 20, 5286-5298. https://doi.org/10.3390/molecules20045286

AMA Style

Penesyan A, Gillings M, Paulsen IT. Antibiotic Discovery: Combatting Bacterial Resistance in Cells and in Biofilm Communities. Molecules. 2015; 20(4):5286-5298. https://doi.org/10.3390/molecules20045286

Chicago/Turabian Style

Penesyan, Anahit, Michael Gillings, and Ian T. Paulsen 2015. "Antibiotic Discovery: Combatting Bacterial Resistance in Cells and in Biofilm Communities" Molecules 20, no. 4: 5286-5298. https://doi.org/10.3390/molecules20045286

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop